Loading…
Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes
Background The relationship between the radiological lymph node (rLN) size and survival outcome in node‐negative rectal cancer is still uncertain. In this study, we aimed to explore the role of enlarged rLN in predicting the survival of node‐negative rectal cancers. Methods We retrospectively review...
Saved in:
Published in: | Cancer medicine (Malden, MA) MA), 2023-05, Vol.12 (9), p.10303-10314 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4701-92e3c035bfd7e94c5882638e1f791006291fa944ec290012cfffe626110c64a63 |
container_end_page | 10314 |
container_issue | 9 |
container_start_page | 10303 |
container_title | Cancer medicine (Malden, MA) |
container_volume | 12 |
creator | Peng, Shaoyong Liu, Xiaoxia Li, Yingjie Yu, Huichuan Xie, Yumo Wang, Xiaolin Zhou, Jiaming Zhu, Mingxuan Luo, Yanxin Huang, Meijin |
description | Background
The relationship between the radiological lymph node (rLN) size and survival outcome in node‐negative rectal cancer is still uncertain. In this study, we aimed to explore the role of enlarged rLN in predicting the survival of node‐negative rectal cancers.
Methods
We retrospectively reviewed the records of 722 node‐negative rectal cancer who underwent curative resection. Factors associated with DFS (disease‐free survival) and CSS (cancer‐specific survival) were assessed with univariate and multivariate analysis. Survival analysis was performed according to presence with or without enlarged rLN. Combining rLN with NLR as a new index‐inflammation immune score (IIS) for predicting survival. Comparing different models to assess the predictive powers.
Results
A total of 119 patients had tumor recurrence and 73 patients died due to cancer. Patients with enlarged rLN (≥5 mm) was significantly associated with better DFS (HR:0.517, 95%CI:0.339–0.787, p = 0.002) and CSS (HR:0.43, 95%CI:0.242–0.763, p = 0.004). The risk factors of recurrence were rLN, neutrophil‐lymphocyte ratio (NLR), CEA level, and distance from the anal verge. The risk of recurrence increased by 1.88‐ and 2.83‐fold for the high score in IIS compared with the low and intermediate score group (All p |
doi_str_mv | 10.1002/cam4.5761 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_250841e912c64ee4bdba623c46a49e8b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_250841e912c64ee4bdba623c46a49e8b</doaj_id><sourcerecordid>2788800979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4701-92e3c035bfd7e94c5882638e1f791006291fa944ec290012cfffe626110c64a63</originalsourceid><addsrcrecordid>eNp1ksFu1DAQhiMEolXpgRdAlrjAYVvbcRz7hKoVhUpFSAjOluNMEq-cONjJlnDqG8Az8iR4u23VIuGDPR7__sYe_Vn2kuATgjE9NbpnJ0XJyZPskGJWrEqes6cP4oPsOMYNTqPElJfkeXaQc5kLXhaH2a8vurbe-dYa7ZBb-rH7c_178DWgaH8Csv0Y_BYimjpAKWwHHydr0Fa7GZBvUFziBH3K2KFxuu_1ZP2QNjX8SDMKYKYENnowENCVnTo06qm7q-gWNECb7mwB7YrGF9mzRrsIx7frUfbt_P3X9cfV5ecPF-uzy5VhJSYrSSE3OC-qpi5BMlMIQXkugDSlTF3hVJJGS8bAUIkxoaZpGuCUE4INZ5rnR9nFnlt7vVFjsL0Oi_LaqpuED63SIX3UgaIFFoyATBTOAFhVV5rT3DCumQRRJda7PWucqx5qA8MUtHsEfXwy2E61fqsIprQgkiXCm1tC8N9niJPqbTTgnB7Az1HRUgiBsSxlkr7-R7rxcxhSrxQVRIpC5pQm1du9ygQfY4Dm_jUEq51t1M42amebpH318Pn3yjuTJMHpXnBlHSz_J6n12Sd2g_wLfYzPhg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819859322</pqid></control><display><type>article</type><title>Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes</title><source>ProQuest - Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Peng, Shaoyong ; Liu, Xiaoxia ; Li, Yingjie ; Yu, Huichuan ; Xie, Yumo ; Wang, Xiaolin ; Zhou, Jiaming ; Zhu, Mingxuan ; Luo, Yanxin ; Huang, Meijin</creator><creatorcontrib>Peng, Shaoyong ; Liu, Xiaoxia ; Li, Yingjie ; Yu, Huichuan ; Xie, Yumo ; Wang, Xiaolin ; Zhou, Jiaming ; Zhu, Mingxuan ; Luo, Yanxin ; Huang, Meijin</creatorcontrib><description>Background
The relationship between the radiological lymph node (rLN) size and survival outcome in node‐negative rectal cancer is still uncertain. In this study, we aimed to explore the role of enlarged rLN in predicting the survival of node‐negative rectal cancers.
Methods
We retrospectively reviewed the records of 722 node‐negative rectal cancer who underwent curative resection. Factors associated with DFS (disease‐free survival) and CSS (cancer‐specific survival) were assessed with univariate and multivariate analysis. Survival analysis was performed according to presence with or without enlarged rLN. Combining rLN with NLR as a new index‐inflammation immune score (IIS) for predicting survival. Comparing different models to assess the predictive powers.
Results
A total of 119 patients had tumor recurrence and 73 patients died due to cancer. Patients with enlarged rLN (≥5 mm) was significantly associated with better DFS (HR:0.517, 95%CI:0.339–0.787, p = 0.002) and CSS (HR:0.43, 95%CI:0.242–0.763, p = 0.004). The risk factors of recurrence were rLN, neutrophil‐lymphocyte ratio (NLR), CEA level, and distance from the anal verge. The risk of recurrence increased by 1.88‐ and 2.83‐fold for the high score in IIS compared with the low and intermediate score group (All p < 0.001). Similarly, the high score in IIS also increased the risk of cancer‐specific death. In the model comparison, the AIC and LR were improved by including the rLN into the NLR model for DFS and CSS prediction (All p < 0.05).
Conclusions
Node‐negative rectal cancer patients with enlarged rLN had a better survival outcome. IIS might be a more comprehensive and complete inflammation immune index for survival prediction.</description><identifier>ISSN: 2045-7634</identifier><identifier>EISSN: 2045-7634</identifier><identifier>DOI: 10.1002/cam4.5761</identifier><identifier>PMID: 36938675</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Archives & records ; Cancer ; Colonoscopy ; Colorectal cancer ; Humans ; Inflammation ; Inflammation - pathology ; Leukocytes (neutrophilic) ; Lymph nodes ; Lymph Nodes - diagnostic imaging ; Lymph Nodes - pathology ; Lymph Nodes - surgery ; Lymphatic system ; Lymphocytes ; Metastasis ; Multivariate analysis ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Neutrophils ; NLR ; node‐negative rectal cancer ; Patients ; Prognosis ; radiological lymph node ; Rectal Neoplasms - pathology ; Rectum ; Retrospective Studies ; Risk factors ; Surgery ; survival outcome</subject><ispartof>Cancer medicine (Malden, MA), 2023-05, Vol.12 (9), p.10303-10314</ispartof><rights>2023 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4701-92e3c035bfd7e94c5882638e1f791006291fa944ec290012cfffe626110c64a63</cites><orcidid>0000-0001-8357-1615 ; 0000-0002-5489-4869 ; 0000-0002-8716-2840</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2819859322/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2819859322?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36938675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Shaoyong</creatorcontrib><creatorcontrib>Liu, Xiaoxia</creatorcontrib><creatorcontrib>Li, Yingjie</creatorcontrib><creatorcontrib>Yu, Huichuan</creatorcontrib><creatorcontrib>Xie, Yumo</creatorcontrib><creatorcontrib>Wang, Xiaolin</creatorcontrib><creatorcontrib>Zhou, Jiaming</creatorcontrib><creatorcontrib>Zhu, Mingxuan</creatorcontrib><creatorcontrib>Luo, Yanxin</creatorcontrib><creatorcontrib>Huang, Meijin</creatorcontrib><title>Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes</title><title>Cancer medicine (Malden, MA)</title><addtitle>Cancer Med</addtitle><description>Background
The relationship between the radiological lymph node (rLN) size and survival outcome in node‐negative rectal cancer is still uncertain. In this study, we aimed to explore the role of enlarged rLN in predicting the survival of node‐negative rectal cancers.
Methods
We retrospectively reviewed the records of 722 node‐negative rectal cancer who underwent curative resection. Factors associated with DFS (disease‐free survival) and CSS (cancer‐specific survival) were assessed with univariate and multivariate analysis. Survival analysis was performed according to presence with or without enlarged rLN. Combining rLN with NLR as a new index‐inflammation immune score (IIS) for predicting survival. Comparing different models to assess the predictive powers.
Results
A total of 119 patients had tumor recurrence and 73 patients died due to cancer. Patients with enlarged rLN (≥5 mm) was significantly associated with better DFS (HR:0.517, 95%CI:0.339–0.787, p = 0.002) and CSS (HR:0.43, 95%CI:0.242–0.763, p = 0.004). The risk factors of recurrence were rLN, neutrophil‐lymphocyte ratio (NLR), CEA level, and distance from the anal verge. The risk of recurrence increased by 1.88‐ and 2.83‐fold for the high score in IIS compared with the low and intermediate score group (All p < 0.001). Similarly, the high score in IIS also increased the risk of cancer‐specific death. In the model comparison, the AIC and LR were improved by including the rLN into the NLR model for DFS and CSS prediction (All p < 0.05).
Conclusions
Node‐negative rectal cancer patients with enlarged rLN had a better survival outcome. IIS might be a more comprehensive and complete inflammation immune index for survival prediction.</description><subject>Archives & records</subject><subject>Cancer</subject><subject>Colonoscopy</subject><subject>Colorectal cancer</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammation - pathology</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymph nodes</subject><subject>Lymph Nodes - diagnostic imaging</subject><subject>Lymph Nodes - pathology</subject><subject>Lymph Nodes - surgery</subject><subject>Lymphatic system</subject><subject>Lymphocytes</subject><subject>Metastasis</subject><subject>Multivariate analysis</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Neutrophils</subject><subject>NLR</subject><subject>node‐negative rectal cancer</subject><subject>Patients</subject><subject>Prognosis</subject><subject>radiological lymph node</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectum</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Surgery</subject><subject>survival outcome</subject><issn>2045-7634</issn><issn>2045-7634</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ksFu1DAQhiMEolXpgRdAlrjAYVvbcRz7hKoVhUpFSAjOluNMEq-cONjJlnDqG8Az8iR4u23VIuGDPR7__sYe_Vn2kuATgjE9NbpnJ0XJyZPskGJWrEqes6cP4oPsOMYNTqPElJfkeXaQc5kLXhaH2a8vurbe-dYa7ZBb-rH7c_178DWgaH8Csv0Y_BYimjpAKWwHHydr0Fa7GZBvUFziBH3K2KFxuu_1ZP2QNjX8SDMKYKYENnowENCVnTo06qm7q-gWNECb7mwB7YrGF9mzRrsIx7frUfbt_P3X9cfV5ecPF-uzy5VhJSYrSSE3OC-qpi5BMlMIQXkugDSlTF3hVJJGS8bAUIkxoaZpGuCUE4INZ5rnR9nFnlt7vVFjsL0Oi_LaqpuED63SIX3UgaIFFoyATBTOAFhVV5rT3DCumQRRJda7PWucqx5qA8MUtHsEfXwy2E61fqsIprQgkiXCm1tC8N9niJPqbTTgnB7Az1HRUgiBsSxlkr7-R7rxcxhSrxQVRIpC5pQm1du9ygQfY4Dm_jUEq51t1M42amebpH318Pn3yjuTJMHpXnBlHSz_J6n12Sd2g_wLfYzPhg</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Peng, Shaoyong</creator><creator>Liu, Xiaoxia</creator><creator>Li, Yingjie</creator><creator>Yu, Huichuan</creator><creator>Xie, Yumo</creator><creator>Wang, Xiaolin</creator><creator>Zhou, Jiaming</creator><creator>Zhu, Mingxuan</creator><creator>Luo, Yanxin</creator><creator>Huang, Meijin</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8357-1615</orcidid><orcidid>https://orcid.org/0000-0002-5489-4869</orcidid><orcidid>https://orcid.org/0000-0002-8716-2840</orcidid></search><sort><creationdate>202305</creationdate><title>Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes</title><author>Peng, Shaoyong ; Liu, Xiaoxia ; Li, Yingjie ; Yu, Huichuan ; Xie, Yumo ; Wang, Xiaolin ; Zhou, Jiaming ; Zhu, Mingxuan ; Luo, Yanxin ; Huang, Meijin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4701-92e3c035bfd7e94c5882638e1f791006291fa944ec290012cfffe626110c64a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Archives & records</topic><topic>Cancer</topic><topic>Colonoscopy</topic><topic>Colorectal cancer</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammation - pathology</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymph nodes</topic><topic>Lymph Nodes - diagnostic imaging</topic><topic>Lymph Nodes - pathology</topic><topic>Lymph Nodes - surgery</topic><topic>Lymphatic system</topic><topic>Lymphocytes</topic><topic>Metastasis</topic><topic>Multivariate analysis</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Neutrophils</topic><topic>NLR</topic><topic>node‐negative rectal cancer</topic><topic>Patients</topic><topic>Prognosis</topic><topic>radiological lymph node</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectum</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Surgery</topic><topic>survival outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Shaoyong</creatorcontrib><creatorcontrib>Liu, Xiaoxia</creatorcontrib><creatorcontrib>Li, Yingjie</creatorcontrib><creatorcontrib>Yu, Huichuan</creatorcontrib><creatorcontrib>Xie, Yumo</creatorcontrib><creatorcontrib>Wang, Xiaolin</creatorcontrib><creatorcontrib>Zhou, Jiaming</creatorcontrib><creatorcontrib>Zhu, Mingxuan</creatorcontrib><creatorcontrib>Luo, Yanxin</creatorcontrib><creatorcontrib>Huang, Meijin</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer medicine (Malden, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Shaoyong</au><au>Liu, Xiaoxia</au><au>Li, Yingjie</au><au>Yu, Huichuan</au><au>Xie, Yumo</au><au>Wang, Xiaolin</au><au>Zhou, Jiaming</au><au>Zhu, Mingxuan</au><au>Luo, Yanxin</au><au>Huang, Meijin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes</atitle><jtitle>Cancer medicine (Malden, MA)</jtitle><addtitle>Cancer Med</addtitle><date>2023-05</date><risdate>2023</risdate><volume>12</volume><issue>9</issue><spage>10303</spage><epage>10314</epage><pages>10303-10314</pages><issn>2045-7634</issn><eissn>2045-7634</eissn><abstract>Background
The relationship between the radiological lymph node (rLN) size and survival outcome in node‐negative rectal cancer is still uncertain. In this study, we aimed to explore the role of enlarged rLN in predicting the survival of node‐negative rectal cancers.
Methods
We retrospectively reviewed the records of 722 node‐negative rectal cancer who underwent curative resection. Factors associated with DFS (disease‐free survival) and CSS (cancer‐specific survival) were assessed with univariate and multivariate analysis. Survival analysis was performed according to presence with or without enlarged rLN. Combining rLN with NLR as a new index‐inflammation immune score (IIS) for predicting survival. Comparing different models to assess the predictive powers.
Results
A total of 119 patients had tumor recurrence and 73 patients died due to cancer. Patients with enlarged rLN (≥5 mm) was significantly associated with better DFS (HR:0.517, 95%CI:0.339–0.787, p = 0.002) and CSS (HR:0.43, 95%CI:0.242–0.763, p = 0.004). The risk factors of recurrence were rLN, neutrophil‐lymphocyte ratio (NLR), CEA level, and distance from the anal verge. The risk of recurrence increased by 1.88‐ and 2.83‐fold for the high score in IIS compared with the low and intermediate score group (All p < 0.001). Similarly, the high score in IIS also increased the risk of cancer‐specific death. In the model comparison, the AIC and LR were improved by including the rLN into the NLR model for DFS and CSS prediction (All p < 0.05).
Conclusions
Node‐negative rectal cancer patients with enlarged rLN had a better survival outcome. IIS might be a more comprehensive and complete inflammation immune index for survival prediction.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>36938675</pmid><doi>10.1002/cam4.5761</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-8357-1615</orcidid><orcidid>https://orcid.org/0000-0002-5489-4869</orcidid><orcidid>https://orcid.org/0000-0002-8716-2840</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-7634 |
ispartof | Cancer medicine (Malden, MA), 2023-05, Vol.12 (9), p.10303-10314 |
issn | 2045-7634 2045-7634 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_250841e912c64ee4bdba623c46a49e8b |
source | ProQuest - Publicly Available Content Database; Wiley Open Access; PubMed Central |
subjects | Archives & records Cancer Colonoscopy Colorectal cancer Humans Inflammation Inflammation - pathology Leukocytes (neutrophilic) Lymph nodes Lymph Nodes - diagnostic imaging Lymph Nodes - pathology Lymph Nodes - surgery Lymphatic system Lymphocytes Metastasis Multivariate analysis Neoplasm Recurrence, Local - pathology Neoplasm Staging Neutrophils NLR node‐negative rectal cancer Patients Prognosis radiological lymph node Rectal Neoplasms - pathology Rectum Retrospective Studies Risk factors Surgery survival outcome |
title | Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A11%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiological%20lymph%E2%80%90node%20size%20improves%20the%20prognostic%20value%20of%20systemic%20inflammation%20index%20in%20rectal%20cancer%20with%20pathologically%20negative%20nodes&rft.jtitle=Cancer%20medicine%20(Malden,%20MA)&rft.au=Peng,%20Shaoyong&rft.date=2023-05&rft.volume=12&rft.issue=9&rft.spage=10303&rft.epage=10314&rft.pages=10303-10314&rft.issn=2045-7634&rft.eissn=2045-7634&rft_id=info:doi/10.1002/cam4.5761&rft_dat=%3Cproquest_doaj_%3E2788800979%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4701-92e3c035bfd7e94c5882638e1f791006291fa944ec290012cfffe626110c64a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2819859322&rft_id=info:pmid/36938675&rfr_iscdi=true |